Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Clinical trial NCT02396212 · COMPLETED

Trial details

NCT number: NCT02396212
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Juvenile Idiopathic Arthritis

Start date: 2015-05-07
Primary completion: 2017-03-07
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.